FLNT vs CDLX

For growth investors, Cardlytics, Inc.

(CDLX) is the stronger pick with -16. 2% revenue growth year-over-year, versus -18. 0% for Fluent, Inc. (FLNT). Analysts rate Fluent, Inc. (FLNT) a "Hold" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Fluent, Inc.

(FLNT) delivered a total return of -86. 6%, compared to -99. 2% for Cardlytics, Inc. (CDLX). Over 10 years, the gap is even starker: FLNT returned -90. 7% versus CDLX's -94. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Fluent, Inc.

(FLNT) is the lower-risk stock at 1. 14β versus Cardlytics, Inc. 's 3. 18β — meaning CDLX is approximately 180% more volatile than FLNT relative to the S&P 500.

By revenue growth (latest reported year), Cardlytics, Inc.

(CDLX) is pulling ahead at -16. 2% versus -18. 0% for Fluent, Inc. (FLNT). On earnings-per-share growth, the picture is similar: Cardlytics, Inc. grew EPS 50. 1% year-over-year, compared to 41. 7% for Fluent, Inc.. Over a 3-year CAGR, CDLX leads at -7. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Fluent, Inc.

(FLNT) is the more profitable company, earning -13. 0% net margin versus -44. 4% for Cardlytics, Inc. — meaning it keeps -13. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FLNT leads at -9. 7% versus -20. 2% for CDLX. At the gross margin level — before operating expenses — CDLX leads at 45. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Fluent, Inc.

(FLNT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 14)). Cardlytics, Inc. (CDLX) carries a higher beta of 3. 18 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (FLNT: -90. 7%, CDLX: -94. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Communication Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.